KLRK1 and neoplasm: circTRIM33-12 expression level was positively correlated with NKG2D-positive cell numbers in HCC, suggesting that circTRIM33-12 sponged miR-191/TET1 and exerted an anti-tumor function by not only participating in the tumor proliferation–related signaling pathway, but also contributing to immune surveillance and T cell activation [136].